PolarityTE, Inc. (NASDAQ:PTE – Get Rating) – Investment analysts at Northland Capmk issued their Q1 2023 earnings estimates for PolarityTE in a research note issued on Wednesday, March 29th. Northland Capmk analyst C. Byrnes anticipates that the company will post earnings per share of ($0.69) for the quarter. The consensus estimate for PolarityTE's current full-year earnings is ($4.60) per share. Northland Capmk also issued estimates for PolarityTE's Q2 2023 earnings at ($0.55) EPS, Q3 2023 earnings at ($0.47) EPS and Q4 2023 earnings at ($0.46) EPS.
Get PolarityTE alerts:Separately, Northland Securities decreased their price objective on shares of PolarityTE from $1.25 to $1.00 and set an "outperform" rating for the company in a research report on Wednesday, December 28th.
PolarityTE Price Performance
Shares of PTE opened at $0.50 on Friday. The firm has a 50-day moving average of $0.73 and a 200-day moving average of $0.74. PolarityTE has a one year low of $0.41 and a one year high of $12.00. The company has a market cap of $3.69 million, a PE ratio of -0.08 and a beta of 1.21.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of the company. LPL Financial LLC bought a new stake in shares of PolarityTE during the 4th quarter worth about $189,000. First Republic Investment Management Inc. raised its stake in PolarityTE by 554.6% in the 1st quarter. First Republic Investment Management Inc. now owns 108,662 shares of the company's stock worth $27,000 after purchasing an additional 92,062 shares in the last quarter. Renaissance Technologies LLC raised its stake in PolarityTE by 55.2% in the 3rd quarter. Renaissance Technologies LLC now owns 67,222 shares of the company's stock worth $58,000 after purchasing an additional 23,900 shares in the last quarter. Finally, Prudential Financial Inc. acquired a new stake in PolarityTE in the 2nd quarter worth about $25,000. Institutional investors own 11.75% of the company's stock.
PolarityTE Company Profile
(Get Rating)
PolarityTE, Inc is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The firm products include SkinTE Cryo, SkinTE POC, PTE 11000, OsteoTE and Real Time Assistant. Its SkinTE product is commercially available for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts.
See Also
- Get a free copy of the StockNews.com research report on PolarityTE (PTE)
- MarketBeat Week in Review – 3/27 – 3/31
- What is a Gold IRA, and is it a Viable Investment?
- Is Braze Inc Ready To Rocket Higher?
- Mullen Automotive Makes Deliveries; Short-Squeeze Possible
- Can Frontline Maintain This Momentum?
Receive News & Ratings for PolarityTE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PolarityTE and related companies with MarketBeat.com's FREE daily email newsletter.
